Pregnancy, like most biologic phenomena, involves the action of cytokines. These proteins have a short half-life and are believed to exert their effect close to their site of production, where diagnostic tests cannot be easily performed. Here we show that the cytokine content in the maternal serum reflects cytokine production and secretion from maternal spleen cells, which also correlates with production from decidual cells. We show that GM-CSF, IL-3, and IL-10 are present in the serum at specific time intervals during the first half of murine pregnancy, which correlates with their production from maternal spleen cells. Purified GM-CSF and IL-3 from spleen-cell-culture supernatants are biologically active molecules, able to stimulate placental-cell proliferation. Furthermore, TNF-0, which has been identified in many cases of fetal rejection as well as in labor, is shown to be naturally produced during the second half of pregnancy. Additionally, within the limits of the sensitivity of the technique we have used, the detection of IL-4 and the absence of detectable levels of IL-2 in the maternal serum strongly comforts the hypothesis that pregnancy is a Th2-dependent phenomenon. The results presented in this paper show that the cytokine profile during pregnancy can be monitored by simple blood tests, which may be of relevance both in the followup of a physiological human pregnancy and to the diagnosis of recurrent abortions due to cytokine imbalance.
INTRODUCTION
During the gestational period, the maternal immune system is being stimulated by paternal alloantigens, which are introduced in the maternal organism through the semi-allogeneic fetus they carry. These alloantigens can be detected either in the maternal blood, where fetal cells have been found to circulate in mice and humans (Douglas et al., 1959; Schroder, 1975; Herzenberg et al., 1979; Bianchi et al., 1990; Bruch et al., 1991) . In mice, they are expressed on the outer trophoblastic layer of the semi-allogeneic placental tissue, which comes in direct contact with the maternal circulation (McLaren, 1975; Raghupathy et al., 1981) . Many studies so far indicate that at the cellular level, the maternal immune stimulation is manifested via two essential mecha-*Corresponding author.
nisms. The first consists of an immunotrophic activity of the maternal immune system toward the developing feto-placental annexes (James, 1965; Wegmann, 1984; 1987) , whereas the second involves an immunosuppressive activity of the maternal immune response toward paternal alloantigens (Slapsys and Clark, 1983, Chaouat et al., 1984; Sano et al., 1984) . For a long time, the immunotrophic and immunosuppressive hypotheses were considered as mutually exclusive and scientists were trying to give evidence for either one. Regarding the immunotrophic hypothesis, there is evidence that maternal T cells and T-cell-derived lymphokines stimulate placental-cell growth and improve fetal survival (Wegmann, 1984; Athanassakis et al., 1987) . On the other hand, the existence of anti-paternal suppressor factors and suppressor cells during pregnancy support the immunosuppressive hypothesis (Smith and Powell, 1977; Engleman, et al., 1978; Slapsys and Clark, 1983; Sano et al., 1984; Clark et al. 1990 ). I. ATHANASSAKIS and B. ICONOMIDOU ever, it is now believed that these two theories are not mutually exclusive and that both drive the maternal organism to cytokine production regulating important steps of successful pregnancy, which is hypothesized to be a Th2-dependent phenomenon .
Here we study six cytokines, referenced to be involved in the process of successful pregnancy. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) have been described to stimulate growth and function of trophoblasts (Athanassakis et al., 1987) . (IL-10) shows a protective effect to the maternofetal allograft, rescuing fetal rejection in abortionprone mice (Chaouat et al., 1995) . Tumor necrosis factor-0 (TNF-a) has been detected in many cases of abortion models and its beneficial or destructive presence during pregnancy is questioned in many instances (Parand and Chedid, 1964; Gendron et al., 1989; Chaouat et al., 1990; Yelavarthi et al., 1991) .
In order to distinguish between Thl and Th2 cell populations, this study also included detection of interleukin-2(IL-2) and (Athanassakis-Vassiliadis, 1993 ), but in the maternal spleen as well (Tsoukatos et al., 1994 Among the cytokines tested so far, special care is given to GM-CSF and IL-3, which are known to fortify the placental barrier by stimulating trophoblast growth and phagocytosis (Athanassakis et al., 1987 (Tsoukatos et al., 1994) . In order to examine whether such cytokine changes can be detected in the maternal serum and whether these reflect the situation observed at specific sites of the maternal organism, in the present study; we compared the cytokine content in the maternal serum from day 6 to 14 of gestation with the growth factors produced and secreted by spleen cells within the same time intervals. The results demonstrate that the cytokine profile in the serum correlates with that of maternal spleen and furthermore with the local production of growth factors by decidual cells (Athanassakis-Vassiliadis, 1993 ).
The profile of GM-CSF, IL-3, IL-10, TNF-c, IL-2, and IL-4 in the maternal serum was determined by ELISA. GM-CSF and IL-3 are known to directly affect fetal development by stimulating trophoblast proliferation, whereas IL-10 has been shown to rescue fetal abortion in mice (Chaouat et al., 1995) . The results show that the production of these lymphokines is not simultaneous, because IL-10 peaks on day 7 of pregnancy, GM-CSF on day 9, and IL-3 on day 10. Consequently, it can be postulated that these factors serve different stages of fetal development. The presence of TNF-0 has been correlated with fetal abortion in many systems (Parand and Chedid, 1964; Gendron et al., 1989; Chaouat et al., 1990) . Here Wegmann et al. (1993) .
In order to define whether spleen is one of the sites of production of such growth factors, we stained maternal spleen cells with specific monoclonal antibodies and showed that indeed IL-10-secreting cells are present in the maternal spleen, following a profile similar to that of maternal serum. Intracellular GM-CSF, which with an exception on day 7 of gestation follows a similar pattern to the seric factor, is also being secreted by spleen cells because it can be detected in the 24-hr culture supernatants of spleen cells at the equivalent days of pregnancy. The highest concentration of IL-3-secreting cells is detected in the spleen of days 6 and 7 of pregnancy, which, however, does not correspond to the highest concentration of the factor detected in the serum. This form of IL-3 is either nonsecreted or it is at the beginning of its biosynthesis, because IL-3 can be detected in the 24-hr culture supernatants from day 9 of pregnancy. Furthermore, GM-CSF and IL-3 secreted by spleen cells are biologically active because they can stimulate placental cells to proliferate. The differences observed between seric and intracellular growth factors can be due to the presence of soluble receptors, to different sites of action as well as to the difference in factor half-life, points that need to be investigated in the future. The factors studied here are naturally not the only ones involved in the gestational process. Indeed, when fractions of the 24-hr-spleen-cell culture supernatants, other than IL-3 and GM-CSF, were applied to placental cells, these were able to stimulate growth.
These results give new insight in the regulatory mechanisms taking place during pregnancy. Each growth factor follows a specific pattern of production, likely to serve specific needs of the materno/ fetal organism during gestation. One important observation is that growth-factor production is a systemic phenomenon during pregnancy and that its presence in the maternal serum correlates with its production from spleen and possibly other sites close to the feto-placental unit. A similar method as the one used for the murine growth-factor profiles analyzed here may be employed in humans, to allow to study the physiological levels of cytokines throughout the gestational period. Several abortive causes have been correlated to specific growth factor over or under production. Therefore, with simple blood tests, we may follow not only the progress of fetal development, but we can also prognose cases of recurrent abortion.
without serum for 24 hr at a concentration of I x 10 cells/ml. Culture supernatants (10 ml) were collected after centrifugation of the cells at 1200 rpm for 10 min. Three mice were tested in each day of pregnancy in the allogeneic and syngeneic situation.
Partial Fractionation of Spleen-Cell Supernatants This fractionation was performed as described by Tsoukatos et al. (1994) 
MATERIALS AND METHODS
Placental Cell Cultures Mice BALB/cJ(H-2d) 6-8 weeks old were maintained in the animal facility at the University of Crete (Crete, Greece). Each female was checked for oestrus, caged overnight with a BALB/cJ male, and checked for the presence of a vaginal plug on the following morning. The day on which the plug was observed was considered to be day 0 of pregnancy.
Antibodies
Rat anti-mouse IgG2a monoclonal antibodies to the growth factors GM-CSF (sensitivity 5 tg/ml), (sensitivity 3 tg/ml), IL-10 (sensitivity 0.14 U/ml), TNF-(sensitivity 25 f)g/ml), IL-2 and IL-4 (sensitivity 5 tg/ml) were purchased from Endogen Inc. (Cambridge, MA), and were used at the concentration of I tg/ml. Spleen-Cell Cultures Spleens were obtained either from pregnant or control nonpregnant BALB/cJ females from day 9 to 13 of gestation. Cell suspensions were washed in Hank's solution (Gibco, Grand Island, NY) three times and cultured in RPMI 1640 medium (Gibco) Placental cell cultures were performed as described by Athanassakis et al. (1987) with slight modifications. Briefly, placentas were isolated from females on day 11 to 14 of gestation and after removing the maternally derived decidual cap layer from all placentas, the tissues were cut in small pieces, and single-cell suspensions were prepared by passing the preparation through a syringe with a 18-G needle, into Hank's solution (Athanassakis et al. 1987; , which are also found to be cytokeratin-positive and vimentin-negative (trophoblasts; Athanassakis, 1987 Immunofluorescent staining of cytoplasmic growthfactor production was performed as described by Sander et al. (1991) . Maternal spleen cells from day 6 to 14 pregnancy were put in a single-cell suspension, washed several times, and fixed with ice-cold paraformaldehyde (4% in PBS) for 5 min. After washing, the cells were incubated for 30 min at room temperature with specific antibodies diluted in a HBSS-Saponin solution (HBSS; Gibco, 0.01 M Hepes; Gibco, 0.1% Saponin, Sigma). After washing in PBSSaponin, the cells were incubated with rabbit antirat IgG antibody FITC-conjugated for 30 min at room temperature. The cells were washed, fixed with 25% glycerol, mounted on slides, and examined for cytoplasmic staining using a Leitz fluorescent microscope.
